Acute Mountain Sickness Clinical Trial
In this investigation the researchers explore whether different types of breathing procedures can improve the peripheral oxygen saturation to reduce the risk of becoming a acute mountain sickness or a high altitude pulmonary edema.
Acute mountain sickness (AMS) is a pathological effect of high altitude on humans caused by
acute exposure to low partial pressure of oxygen at high altitude. It commonly occurs above
2500 meters of altitude. AMS appears as a collection of nonspecific symptoms acquired at
high altitude or in low air pressure resembling a case of "flu, carbon monoxide poisoning,
or a hangover".
It is caused by a drop in pressure and lowering partial pressure of oxygen during increasing
altitude. The direct consequence of those changes is a hypoxic pulmonary vasoconstriction
(Euler-Lijestrand-mechanism). In addition a rise in pulmonary blood pressure (Hypertonia)
can occur so that there is a higher risk of developing a high altitude pulmonary edema
(HAPE).
In this investigation the investigators are exploring whether different types of breathing
procedures can improve the peripheral oxygen saturation. We are comparing breathing with no
regulation with two different procedures of hyperventilation during trekking in different
altitudes. Procedure 1 (hyperventilation 1) describes inhalation during one step and
exhalation during the next step. Procedure 2 (hyperventilation 2) describes inhalation and
exhalation during one step.
The effect of the different breathing procedures can be quantified measuring the peripheral
oxygen saturation. In addition the investigators are comparing the breathing rate and the
minute ventilation as well as the expiratory end-tidal CO2-partial pressure of the three
different breathing procedures.
Furthermore, the investigators are examining the ability to concentrate in order to quantify
the effect of AMS on organ functions.
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04111263 -
Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude
|
N/A | |
Completed |
NCT01842906 -
Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)
|
N/A | |
Completed |
NCT01536288 -
Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness
|
Phase 2 | |
Completed |
NCT00326703 -
Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort
|
N/A | |
Completed |
NCT06310642 -
Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness
|
Phase 4 | |
Completed |
NCT03561675 -
Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years
|
Phase 4 | |
Completed |
NCT00559832 -
Prevention of Acute Mountain Sickness by Intermittent Hypoxia
|
N/A | |
Completed |
NCT01436383 -
Oxidative Stress in Hypobaric Hypoxia
|
N/A | |
Completed |
NCT00603122 -
Acclimatization Mechanisms During Ascent to 7500m
|
N/A | |
Completed |
NCT00664001 -
Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness
|
Phase 3 | |
Completed |
NCT00627965 -
Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness
|
Phase 4 | |
Not yet recruiting |
NCT06145113 -
The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness
|
N/A | |
Recruiting |
NCT05733338 -
The Effects of Intermittent Hypoxia on Acute Hypoxic Injury
|
N/A | |
Completed |
NCT01522326 -
Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness
|
N/A | |
Recruiting |
NCT06393998 -
CO2 Supplement for Treatment of Acute Mountain Sickness
|
N/A | |
Completed |
NCT03270787 -
Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness
|
Phase 1/Phase 2 | |
Completed |
NCT02811016 -
Inhaled Budesonide and Acute Mountain Sickness
|
Phase 1 | |
Recruiting |
NCT00886912 -
Training in Hypoxia to Prevent Acute Mountain Sickness
|
N/A | |
Terminated |
NCT03956472 -
Alternative Treatments in Acute Mountain Sickness
|
N/A | |
Recruiting |
NCT03621410 -
T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) During Rapid Ascent
|
Phase 2 |